Jackson J C, Vinluan C C, Dragland C J, Sundararajan V, Yan B, Gounarides J S, Nirmala N R, Topiol S, Ramage P, Blume J E, Aicher T D, Bell P A, Mann W R
Metabolic and Cardiovascular Diseases Research, Novartis Institute for Biomedical Research, 556 Morris Avenue, Summit, NJ 07901-1398, USA.
Biochem J. 1998 Sep 15;334 ( Pt 3)(Pt 3):703-11. doi: 10.1042/bj3340703.
The activity of the pyruvate dehydrogenase multienzyme complex (PDC), which catalyses the oxidation of pyruvate to acetyl-CoA within the mitochondrion, is diminished in animal models of diabetes. Studies with purified PDC components have suggested that the kinases responsible for inactivating the decarboxylase catalytic subunits of the complex are most efficient in their regulatory role when they are bound to dihydrolipoyl acetyltransferase (E2) subunits, which form the structural core of the complex. We report that the addition of an exogenous E2 subdomain (inner lipoyl domain) to an intact PDC inhibits ATP-dependent inactivation of the complex. By combining molecular modelling, site-directed mutagenesis and biophysical characterizations, we have also identified two amino acid residues in this subdomain (Ile229 and Phe231) that largely determine the magnitude of this effect.
丙酮酸脱氢酶多酶复合体(PDC)在线粒体内催化丙酮酸氧化为乙酰辅酶A,其活性在糖尿病动物模型中降低。对纯化的PDC组分的研究表明,负责使该复合体的脱羧酶催化亚基失活的激酶,在与构成该复合体结构核心的二氢硫辛酰乙酰转移酶(E2)亚基结合时,其调节作用最为有效。我们报告称,向完整的PDC添加外源E2亚结构域(内部硫辛酰结构域)可抑制该复合体的ATP依赖性失活。通过结合分子建模、定点诱变和生物物理表征,我们还在该亚结构域中确定了两个氨基酸残基(Ile229和Phe231),它们在很大程度上决定了这种效应的大小。